FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle

The mammalian target of rapamycin (mTOR) is regulated by growth factors to promote protein synthesis. In mammalian skeletal muscle, the Forkhead-O1 transcription factor (FOXO1) promotes catabolism by activating ubiquitin-protein ligases. Using C2C12 mouse myoblasts that stably express inducible FOXO...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry Vol. 282; no. 29; pp. 21176 - 21186
Main Authors: Southgate, Robert J., Neill, Bronwyn, Prelovsek, Oja, El-Osta, Assam, Kamei, Yasutomi, Miura, Shinji, Ezaki, Osamu, McLoughlin, Thomas J., Zhang, Wenwei, Unterman, Terry G., Febbraio, Mark A.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 20-07-2007
American Society for Biochemistry and Molecular Biology
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The mammalian target of rapamycin (mTOR) is regulated by growth factors to promote protein synthesis. In mammalian skeletal muscle, the Forkhead-O1 transcription factor (FOXO1) promotes catabolism by activating ubiquitin-protein ligases. Using C2C12 mouse myoblasts that stably express inducible FOXO1-ER fusion proteins and transgenic mice that specifically overexpress constitutively active FOXO1 in skeletal muscle (FOXO++/+), we show that FOXO1 inhibits mTOR signaling and protein synthesis. Activation of constitutively active FOXO1 induced the expression of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) mRNA via binding to the promoter. This resulted in an increased total 4E-BP1 abundance and a reduced 4E-BP1 (Thr-37/46) phosphorylation. The reduction in 4E-BP1 phosphorylation was associated with a reduction in the abundance of Raptor and mTOR proteins, Raptor-associated mTOR, reduced phosphorylation of the downstream protein p70S6 kinase, and attenuated incorporation of [14C]phenylalanine into protein. The FOXO++/+ mice, characterized by severe skeletal muscle atrophy, displayed similar patterns of mRNA expression and protein abundance to those observed in the constitutively active FOXO1 C2C12 myotubes. These data suggest that FOXO1 may be an important therapeutic target for human diseases where anabolism is impaired.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-2
ObjectType-Feature-3
content type line 23
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M702039200